An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets
2017 · Journal of Hematology & Oncology · 42 citations
https://doi.org/10.1186/s13045-017-0465-4
A
Andrew D. Kelly
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
954
Citations
13
h-index
18
i10-index
Andrew D. Kelly is an academic researcher from Emergency Medicine Foundation. The author has contributed to research in topics: Epigenetics and DNA Methylation & Acute Myeloid Leukemia Research & Cancer Genomics and Diagnostics. The author has an h-index of 13, co-authored 51 publications.
ORCID: 0000-0002-5338-7689Papers by this author
worksGenomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
2019 · Clinical Epigenetics · 28 citations
https://doi.org/10.1186/s13148-019-0704-3
A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study
2012 · BMC Genomics · 4 citations
https://doi.org/10.1186/1471-2164-13-332
Incremental analysis of constraint logic programs
2021 · Figshare · 0 citations
https://doi.org/10.26180/14928618.v1
Additional file 3: of An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3780044_d8.v1
Additional file 2: of Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.8981630
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat